RSS Subscribe to our Nanotechnology Business News feed

SurModics And EGEN Partner For Feasibility Study of Controlled Release of siRNA Nanocomplexes

SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the healthcare industry and EGEN, Inc., a privately held biopharmaceutical company focused on developing nucleic acid (DNA and RNAi) therapeutics for the treatment of human diseases, are pleased to announce they have executed a continuation of their feasibility collaboration focused on long-term controlled release of siRNA complexes.

Jul 28th, 2010

Read more

Osram's New Chip Platform Increases LED Efficiency By 30%

The latest generation of thin-film chips benefit from an optimized chip platform which has potential for further improvements. This boost in efficiency is opening up new LED applications in general illumination, in projection and in the industrial sector.

Jul 26th, 2010

Read more